dihexa cancer risk hgf c-met targets neurotrophic factors like BDNF and NGF, which drive brain repair. By activating the receptor, it helps cells take in nutrients and rebuild—especially in cases where recovery is Dihexa (PNB-0408) | c-Met/HGFR Activator
Dihexa (PNB 0408) c Met HGFR Activator MedChemExpress Frontiers Hepatocyte growth factor mimetic protects lateral line hair cells from aminoglycoside exposure The HGF c Met Axis: A Promising Therapeutic Target in Cancer Frontiers Research Topic Targeting cancer associated fibroblast activated HGF c MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity ScienceDirect HGF c Met pathway facilitates the perineural invasion of pancreatic cancer by activating the mTOR NGF axis Cell Death & Disease dihexa hgf c met cancer risk HGF c MET pathway in cancer: from molecular characterization to clinical evidence Targeted Inhibition of Hepatocyte Growth
Pay in 4 interest-free payments of $6.31 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12





